![Chris Pemberton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Gary Pace | M | 76 |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
Judith Swain | M | 75 |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
Roland Toder | M | - |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
Colin Ernest Dawson | M | - |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 9 anni |
Kieran Craig Jina | M | - |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 5 anni |
David Christensen | M | - |
Upstream Medical Technologies Ltd.
![]() Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Nuova-Zelanda | 6 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Chris Pemberton
- Contatti personali